The majority of large health systems and oncology provider groups use clinical pathways in their efforts to standardize cancer treatment, improve patient outcomes, and control costs. According to a recent survey, 70% of healthcare decision-makers use clinical pathways at their organization,¹ and pathway adherence rates of ~80% are reported by one of our panelists.
In this 4-episode video series, Dr Evan Slater and Dr Sophia Humphreys share their perspectives on implementing clinical pathways and measuring the impact.
Episode 1 Implementing Clinical Pathways in Oncology
Shared decision-making is an important part of value-based care, and while pathways are designed to provide guidance, they are not mandated and physicians are free to tailor their treatment approach as needed for their patients.



